Brought to you by:
Wrapsody WAVE trial demonstrates superior patency versus standard of care in AV fistula patients
Merit Medical has today announced positive six-month findings from the randomized arteriovenous (AV) fistula arm of its Wrapsody arteriovenous access efficacy (WAVE) pivotal trial. The data were shown at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) annual congress…
Philips announces FDA approval for enhanced LumiGuide guidewire, marks 1000th patient treated with 3D guidance technology
Royal Philips today announced the introduction of the 160cm Food and Drug Administration (FDA)-approved version of its LumiGuide endovascular navigation wire. This enhanced LumiGuide guidewire, which utilises the company’s Fiber Optic RealShape (FORS) technology, was used for the first time…
VQI analysis of CLTI practice following BEST-CLI finds no pick up in bypass rate
A Vascular Quality Initiative (VQI) analysis of evolving practice in the wake of the BEST-CLI trial demonstrated no increase in the rate of surgical bypass in the year afterwards. More analysis needs to be done comparing the data pre- and…
Muck takes over Midwestern Vascular Surgical Society presidency
Patrick Muck, MD, assumed the reins of the Midwestern Vascular Surgical Society (MVSS) at the conclusion of the 2024 MVSS annual meeting in Chicago (Sept. 12–14). The chief of vascular surgery at Good Samaritan Hospital in Cincinnati, Ohio, took over…
Pilot study looks at undiagnosed vascular disease in homeless
A pilot study in Canadian capital Ottawa aimed at uncovering the extent of undiagnosed vascular disease among the city’s homeless population detected a subset who may be in need of treatment for venous disease. The work was carried out by…
Argon Medical announces launch of peripheral venous thrombectomy system
Argon Medical has today announced the launch of the Cleaner Vac thrombectomy system for the removal of blood clot from the peripheral venous vasculature. The Cleaner Vac thrombectomy system is a disposable, large-bore aspiration system designed to quickly and effectively…
New OBL column to launch in October issue
Vascular Specialist is launching a new column in the October issue of the newspaper dedicated to issues important to—and involving—the office-based lab (OBL) setting. Entitled “The Outpatient,” it will run bimonthly (or six times per year) and be edited by…
‘Select CLTI patients may be safely treated in the office-based lab’
Results from a single-center analysis show the outpatient setting met SVS objective performance goals. A retrospective study of endovascular interventions performed for chronic limb-threatening ischemia (CLTI) in an office-based lab (OBL) associated with a large New York City medical center…
Shockwave Medical expands US peripheral IVL portfolio with enhanced catheter
Shockwave Medical, part of Johnson & Johnson MedTech, has announced the full U.S. launch of its Shockwave E8 peripheral intravascular lithotripsy (IVL) catheter, following clearance by the Food and Drug Administration (FDA). A company press release details that the Shockwave…
The top 10 most popular Vascular Specialist stories of August 2024
In August, the most read stories from Vascular Specialist included a research letter addressing ‘alarmingly high’ mortality rates in chronic limb-threatening ischemia (CLTI) patients; a new book published due to the SVS History Work Group’s recent project; new funding for the development…